Janssen Pharmaceuticals
Recent News About Janssen Pharmaceuticals View More
-
Plaintiff counsel: Independent biostatistician tapped to review Risperdal data was actually J&J consultant
PHILADELPHIA – A plaintiff attorney in the punitive damages trial for Risperdal argued Friday that an independent biostatistician who reviewed the drug’s data for a reanalysis conducted in 2015, was in fact a former consultant for Johnson & Johnson who had worked on other litigation the company was involved in.